A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost-Effectiveness Analysis

被引:12
|
作者
Djalalov, Sandjar [1 ,2 ,3 ]
Beca, Jaclyn [4 ]
Ewara, Emmanuel M. [5 ]
Hoch, Jeffrey S. [6 ]
机构
[1] Westminster Int Univ Tashkent, 12 Istiqbol St, Tashkent 100047, Uzbekistan
[2] Tashkent Pharmaceut Inst, 45 Aybek St, Tashkent 100015, Uzbekistan
[3] Toronto Gen Hosp, Toronto Hlth Econ & Technol Assessment THETA Coll, Eaton Bldg,10th Floor,Room 248,200 Elizabeth St, Toronto, ON M5G 2C4, Canada
[4] Canc Care Ontario, Toronto, ON, Canada
[5] Janssen Inc, 19 Green Belt Dr, Toronto, ON M3C 1L9, Canada
[6] Univ Calif Davis, Dept Publ Hlth Sci, Div Hlth Policy & Management, Davis, CA 95616 USA
关键词
ECONOMIC EVALUATIONS;
D O I
10.1007/s40273-019-00830-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives The aim of this study was to use Microsoft Excel spreadsheet software to fit parametric survival distributions. We also explain the differences between individual patient data (IPD) and survival data reconstructed in Excel and SAS. Methods Three sets of patient data on overall survival were compared using different methods: 'original' IPD, 'reconstructed SAS', and 'reconstructed Excel'. The best-fit distribution was selected using visual observation, supported by linear plots of predicted probabilities, goodness-of-fit coefficients, and the sum of squared error of prediction. Outcomes included the incremental cost-effectiveness ratio (ICER), incremental net benefit (INB), incremental cost, and life-years gained over short-term and lifetime horizons. These were compared for different data sets. Results In this example, log-normal, log-logistic, and Weibull distributions showed best-fit with the visual tests and goodness-of-fit statistics. Weibull and exponential distributions showed significant differences compared with IPD data. Data on short-term (5 years) time horizons produced by different data re-creation methods showed closeness with data reconstructed from SAS. The ICER and INB results were dependent on the time horizon and selected parametric distribution from the model. Conclusions Different approaches used in fitting parametric survival distributions yielded predicted probabilities that substantially differed from those using original IPD. Our study highlights the importance of following guidelines for economic evaluations with a systematic approach to parametric survival analysis techniques in order to select best fitting parametric survival distributions.
引用
收藏
页码:1525 / 1536
页数:12
相关论文
共 50 条
  • [1] A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis
    Sandjar Djalalov
    Jaclyn Beca
    Emmanuel M. Ewara
    Jeffrey S. Hoch
    PharmacoEconomics, 2019, 37 : 1525 - 1536
  • [2] Confounding and missing data in cost-effectiveness analysis: Comparing different methods
    Härkänen T.
    Maljanen T.
    Lindfors O.
    Virtala E.
    Knekt P.
    Health Economics Review, 3 (1) : 1 - 11
  • [3] Regression methods for cost-effectiveness analysis with censored data
    Willan, AR
    Lin, DY
    Manca, A
    STATISTICS IN MEDICINE, 2005, 24 (01) : 131 - 145
  • [4] Cost-effectiveness analysis: Methods and applications
    Plank, DN
    COMPARATIVE EDUCATION REVIEW, 2002, 46 (01) : 141 - 143
  • [5] Statistical analysis of cost-effectiveness data
    Ruiz Espejo, Mariano
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2007, 170 : 511 - 512
  • [6] Cost-effectiveness analysis methods for the REACT study
    Duren-Winfield, V
    Berry, MJ
    Jones, SA
    Clark, DH
    Sevick, MA
    WESTERN JOURNAL OF NURSING RESEARCH, 2000, 22 (04) : 460 - 474
  • [7] A COST-EFFECTIVENESS ANALYSIS OF ALOGLIPTIN IN COMPARISON TO SAXAGLIPTIN
    Wingate, L. T.
    Oishi, T. S.
    Ali, Shubar N. S.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [8] A RELATIVE COST-EFFECTIVENESS ANALYSIS OF DIFFERENT METHODS OF SCREENING FOR DIABETIC-RETINOPATHY
    SCULPHER, MJ
    BUXTON, MJ
    FERGUSON, BA
    HUMPHREYS, JE
    ALTMAN, JFB
    SPIEGELHALTER, DJ
    KIRBY, AJ
    JACOB, JS
    BACON, H
    DUDBRIDGE, SB
    STEAD, JW
    FEEST, TG
    CHENG, H
    FRANKLIN, SL
    COURTNEY, P
    TALBOT, JF
    AHMED, R
    DABBS, TR
    DIABETIC MEDICINE, 1991, 8 (07) : 644 - 650
  • [9] Issues in the Analysis of Longitudinal Cost-effectiveness Data
    Wetzelaer, Pim
    Arntz, Arnoud
    Evers, Silvia M. A. A.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2013, 16 : S38 - S38
  • [10] Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer
    Rossi, Sabrina H.
    Blick, Christopher
    Nathan, Paul
    Nicol, David
    Stewart, Grant D.
    Wilson, Edward C. F.
    VALUE IN HEALTH, 2019, 22 (09) : 981 - 987